Methods for treating cancer using TOR kinase inhibitor combination therapy
US9782427B2 · kind B2 · utility
3Cited by
25References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 16, 2014 |
| Grant date | Oct 10, 2017 |
| Priority date | — |
| Expiry date | Mar 28, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor having the following formula (I):and an effective amount of a cytidine analog, such as 5-azacytidine, to a patient having a cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.